Application of rivaroxaban in patients with non-valvular atrial fibrillation and end-stage kidney disease: A systematic review and meta-analysis

Application of rivaroxaban in patients with non-valvular atrial fibrillation and end-stage kidney disease: A systematic review and meta-analysis

BackgroundNowadays, the number of patients with non-valvular atrial fibrillation (NVAF) complicated by end-stage renal disease (ESKD) is increasing. There are significant challenges in anticoagulation with prescription drugs because of the high risk of bleeding and embolism among these patients. How...

Full description

Bibliographic Details
Main Authors: Zhenzhen Yang, Jieya Wang, Ye Yuan, Tian Cheng, Feifei Ren, Songsong Wang, Zhiqing Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-02-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
rivaroxaban
non-valvular atrial fibrillation
end-stage kidney disease
systematic review
meta-analysis
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2023.1021959/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2023.1021959/full

Similar Items